Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group

Hernán Trimarchi, Jonathan Barratt, Daniel C. Cattran, H. Terence Cook, Rosanna Coppo, Mark Haas, Zhi Hong Liu, Ian S.D. Roberts, Yukio Yuzawa, Hong Zhang, John Feehally, Charles E. Alpers, Ana María Asunis, Sean Barbour, Jan U. Becker, Jie Ding, Gabriella Espino, Franco Ferrario, Agnes Fogo, Michelle HladunewichKensuke Joh, Ritsuko Katafuchi, Jicheng Lv, Keiichi Matsuzaki, Koichi Nakanishi, Antonello Pani, Ran Perera, Agnieszka Perkowska-Ptasinska, Heather Reich, Yuko Shima, Maria Fernanda Soares, Yusuke Suzuki, Katsuo Takahashi, Stéphan Troyanov, Jacobien C. Verhave, Suxia Wang, Jan Weening, Robert Wyatt, Nori Yoshikawa, Caihong Zeng

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

Since the Oxford Classification of IgA nephropathy (IgAN) was published in 2009, MEST scores have been increasingly used in clinical practice. Further retrospective cohort studies have confirmed that in biopsy specimens with a minimum of 8 glomeruli, mesangial hypercellularity (M), segmental sclerosis (S), and interstitial fibrosis/tubular atrophy (T) lesions predict clinical outcome. In a larger, more broadly based cohort than in the original Oxford study, crescents (C) are predictive of outcome, and we now recommend that C be added to the MEST score, and biopsy reporting should provide a MEST-C score. Inconsistencies in the reporting of M and endocapillary cellularity (E) lesions have been reported, so a web-based educational tool to assist pathologists has been developed. A large study showed E lesions are predictive of outcome in children and adults, but only in those without immunosuppression. A review of S lesions suggests there may be clinical utility in the subclassification of segmental sclerosis, identifying those cases with evidence of podocyte damage. It has now been shown that combining the MEST score with clinical data at biopsy provides the same predictive power as monitoring clinical data for 2 years; this requires further evaluation to assess earlier effective treatment intervention. The IgAN Classification Working Group has established a well-characterized dataset from a large cohort of adults and children with IgAN that will provide a substrate for further studies to refine risk prediction and clinical utility, including the MEST-C score and other factors.

Original languageEnglish
Pages (from-to)1014-1021
Number of pages8
JournalKidney International
Volume91
Issue number5
DOIs
Publication statusPublished - 01-05-2017

Fingerprint

Immunoglobulin A
Sclerosis
Biopsy
Podocytes
Immunosuppression
Atrophy
Fibrosis
Cohort Studies
Retrospective Studies
Therapeutics
Pathologists
Datasets

All Science Journal Classification (ASJC) codes

  • Nephrology

Cite this

Trimarchi, H., Barratt, J., Cattran, D. C., Cook, H. T., Coppo, R., Haas, M., ... Zeng, C. (2017). Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney International, 91(5), 1014-1021. https://doi.org/10.1016/j.kint.2017.02.003
Trimarchi, Hernán ; Barratt, Jonathan ; Cattran, Daniel C. ; Cook, H. Terence ; Coppo, Rosanna ; Haas, Mark ; Liu, Zhi Hong ; Roberts, Ian S.D. ; Yuzawa, Yukio ; Zhang, Hong ; Feehally, John ; Alpers, Charles E. ; Asunis, Ana María ; Barbour, Sean ; Becker, Jan U. ; Ding, Jie ; Espino, Gabriella ; Ferrario, Franco ; Fogo, Agnes ; Hladunewich, Michelle ; Joh, Kensuke ; Katafuchi, Ritsuko ; Lv, Jicheng ; Matsuzaki, Keiichi ; Nakanishi, Koichi ; Pani, Antonello ; Perera, Ran ; Perkowska-Ptasinska, Agnieszka ; Reich, Heather ; Shima, Yuko ; Soares, Maria Fernanda ; Suzuki, Yusuke ; Takahashi, Katsuo ; Troyanov, Stéphan ; Verhave, Jacobien C. ; Wang, Suxia ; Weening, Jan ; Wyatt, Robert ; Yoshikawa, Nori ; Zeng, Caihong. / Oxford Classification of IgA nephropathy 2016 : an update from the IgA Nephropathy Classification Working Group. In: Kidney International. 2017 ; Vol. 91, No. 5. pp. 1014-1021.
@article{ea57d53c522747c08fa811c403a3d526,
title = "Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group",
abstract = "Since the Oxford Classification of IgA nephropathy (IgAN) was published in 2009, MEST scores have been increasingly used in clinical practice. Further retrospective cohort studies have confirmed that in biopsy specimens with a minimum of 8 glomeruli, mesangial hypercellularity (M), segmental sclerosis (S), and interstitial fibrosis/tubular atrophy (T) lesions predict clinical outcome. In a larger, more broadly based cohort than in the original Oxford study, crescents (C) are predictive of outcome, and we now recommend that C be added to the MEST score, and biopsy reporting should provide a MEST-C score. Inconsistencies in the reporting of M and endocapillary cellularity (E) lesions have been reported, so a web-based educational tool to assist pathologists has been developed. A large study showed E lesions are predictive of outcome in children and adults, but only in those without immunosuppression. A review of S lesions suggests there may be clinical utility in the subclassification of segmental sclerosis, identifying those cases with evidence of podocyte damage. It has now been shown that combining the MEST score with clinical data at biopsy provides the same predictive power as monitoring clinical data for 2 years; this requires further evaluation to assess earlier effective treatment intervention. The IgAN Classification Working Group has established a well-characterized dataset from a large cohort of adults and children with IgAN that will provide a substrate for further studies to refine risk prediction and clinical utility, including the MEST-C score and other factors.",
author = "Hern{\'a}n Trimarchi and Jonathan Barratt and Cattran, {Daniel C.} and Cook, {H. Terence} and Rosanna Coppo and Mark Haas and Liu, {Zhi Hong} and Roberts, {Ian S.D.} and Yukio Yuzawa and Hong Zhang and John Feehally and Alpers, {Charles E.} and Asunis, {Ana Mar{\'i}a} and Sean Barbour and Becker, {Jan U.} and Jie Ding and Gabriella Espino and Franco Ferrario and Agnes Fogo and Michelle Hladunewich and Kensuke Joh and Ritsuko Katafuchi and Jicheng Lv and Keiichi Matsuzaki and Koichi Nakanishi and Antonello Pani and Ran Perera and Agnieszka Perkowska-Ptasinska and Heather Reich and Yuko Shima and Soares, {Maria Fernanda} and Yusuke Suzuki and Katsuo Takahashi and St{\'e}phan Troyanov and Verhave, {Jacobien C.} and Suxia Wang and Jan Weening and Robert Wyatt and Nori Yoshikawa and Caihong Zeng",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/j.kint.2017.02.003",
language = "English",
volume = "91",
pages = "1014--1021",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

Trimarchi, H, Barratt, J, Cattran, DC, Cook, HT, Coppo, R, Haas, M, Liu, ZH, Roberts, ISD, Yuzawa, Y, Zhang, H, Feehally, J, Alpers, CE, Asunis, AM, Barbour, S, Becker, JU, Ding, J, Espino, G, Ferrario, F, Fogo, A, Hladunewich, M, Joh, K, Katafuchi, R, Lv, J, Matsuzaki, K, Nakanishi, K, Pani, A, Perera, R, Perkowska-Ptasinska, A, Reich, H, Shima, Y, Soares, MF, Suzuki, Y, Takahashi, K, Troyanov, S, Verhave, JC, Wang, S, Weening, J, Wyatt, R, Yoshikawa, N & Zeng, C 2017, 'Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group', Kidney International, vol. 91, no. 5, pp. 1014-1021. https://doi.org/10.1016/j.kint.2017.02.003

Oxford Classification of IgA nephropathy 2016 : an update from the IgA Nephropathy Classification Working Group. / Trimarchi, Hernán; Barratt, Jonathan; Cattran, Daniel C.; Cook, H. Terence; Coppo, Rosanna; Haas, Mark; Liu, Zhi Hong; Roberts, Ian S.D.; Yuzawa, Yukio; Zhang, Hong; Feehally, John; Alpers, Charles E.; Asunis, Ana María; Barbour, Sean; Becker, Jan U.; Ding, Jie; Espino, Gabriella; Ferrario, Franco; Fogo, Agnes; Hladunewich, Michelle; Joh, Kensuke; Katafuchi, Ritsuko; Lv, Jicheng; Matsuzaki, Keiichi; Nakanishi, Koichi; Pani, Antonello; Perera, Ran; Perkowska-Ptasinska, Agnieszka; Reich, Heather; Shima, Yuko; Soares, Maria Fernanda; Suzuki, Yusuke; Takahashi, Katsuo; Troyanov, Stéphan; Verhave, Jacobien C.; Wang, Suxia; Weening, Jan; Wyatt, Robert; Yoshikawa, Nori; Zeng, Caihong.

In: Kidney International, Vol. 91, No. 5, 01.05.2017, p. 1014-1021.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Oxford Classification of IgA nephropathy 2016

T2 - an update from the IgA Nephropathy Classification Working Group

AU - Trimarchi, Hernán

AU - Barratt, Jonathan

AU - Cattran, Daniel C.

AU - Cook, H. Terence

AU - Coppo, Rosanna

AU - Haas, Mark

AU - Liu, Zhi Hong

AU - Roberts, Ian S.D.

AU - Yuzawa, Yukio

AU - Zhang, Hong

AU - Feehally, John

AU - Alpers, Charles E.

AU - Asunis, Ana María

AU - Barbour, Sean

AU - Becker, Jan U.

AU - Ding, Jie

AU - Espino, Gabriella

AU - Ferrario, Franco

AU - Fogo, Agnes

AU - Hladunewich, Michelle

AU - Joh, Kensuke

AU - Katafuchi, Ritsuko

AU - Lv, Jicheng

AU - Matsuzaki, Keiichi

AU - Nakanishi, Koichi

AU - Pani, Antonello

AU - Perera, Ran

AU - Perkowska-Ptasinska, Agnieszka

AU - Reich, Heather

AU - Shima, Yuko

AU - Soares, Maria Fernanda

AU - Suzuki, Yusuke

AU - Takahashi, Katsuo

AU - Troyanov, Stéphan

AU - Verhave, Jacobien C.

AU - Wang, Suxia

AU - Weening, Jan

AU - Wyatt, Robert

AU - Yoshikawa, Nori

AU - Zeng, Caihong

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Since the Oxford Classification of IgA nephropathy (IgAN) was published in 2009, MEST scores have been increasingly used in clinical practice. Further retrospective cohort studies have confirmed that in biopsy specimens with a minimum of 8 glomeruli, mesangial hypercellularity (M), segmental sclerosis (S), and interstitial fibrosis/tubular atrophy (T) lesions predict clinical outcome. In a larger, more broadly based cohort than in the original Oxford study, crescents (C) are predictive of outcome, and we now recommend that C be added to the MEST score, and biopsy reporting should provide a MEST-C score. Inconsistencies in the reporting of M and endocapillary cellularity (E) lesions have been reported, so a web-based educational tool to assist pathologists has been developed. A large study showed E lesions are predictive of outcome in children and adults, but only in those without immunosuppression. A review of S lesions suggests there may be clinical utility in the subclassification of segmental sclerosis, identifying those cases with evidence of podocyte damage. It has now been shown that combining the MEST score with clinical data at biopsy provides the same predictive power as monitoring clinical data for 2 years; this requires further evaluation to assess earlier effective treatment intervention. The IgAN Classification Working Group has established a well-characterized dataset from a large cohort of adults and children with IgAN that will provide a substrate for further studies to refine risk prediction and clinical utility, including the MEST-C score and other factors.

AB - Since the Oxford Classification of IgA nephropathy (IgAN) was published in 2009, MEST scores have been increasingly used in clinical practice. Further retrospective cohort studies have confirmed that in biopsy specimens with a minimum of 8 glomeruli, mesangial hypercellularity (M), segmental sclerosis (S), and interstitial fibrosis/tubular atrophy (T) lesions predict clinical outcome. In a larger, more broadly based cohort than in the original Oxford study, crescents (C) are predictive of outcome, and we now recommend that C be added to the MEST score, and biopsy reporting should provide a MEST-C score. Inconsistencies in the reporting of M and endocapillary cellularity (E) lesions have been reported, so a web-based educational tool to assist pathologists has been developed. A large study showed E lesions are predictive of outcome in children and adults, but only in those without immunosuppression. A review of S lesions suggests there may be clinical utility in the subclassification of segmental sclerosis, identifying those cases with evidence of podocyte damage. It has now been shown that combining the MEST score with clinical data at biopsy provides the same predictive power as monitoring clinical data for 2 years; this requires further evaluation to assess earlier effective treatment intervention. The IgAN Classification Working Group has established a well-characterized dataset from a large cohort of adults and children with IgAN that will provide a substrate for further studies to refine risk prediction and clinical utility, including the MEST-C score and other factors.

UR - http://www.scopus.com/inward/record.url?scp=85015786890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015786890&partnerID=8YFLogxK

U2 - 10.1016/j.kint.2017.02.003

DO - 10.1016/j.kint.2017.02.003

M3 - Article

C2 - 28341274

AN - SCOPUS:85015786890

VL - 91

SP - 1014

EP - 1021

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -